View Author
patient antibody jejuni syndrome study ganglioside infection gbs patients nerve guillain-barre syndrome strain serum guillain-barre campylobacter anti-gm 1 antibodies control anti-gm group motor miller fisher syndrome anti-ganglioside antibodies disease treatment structure neurol guillain-barr é syndrome anti-ganglioside table jejuni strains van doorn pa response binding jacob neuropathy presence weakness level fisher elisa muscle result enteriti neurology netherland class doorn score siglec outcome effect campy analysis gbs disability score activity guillain sample axonal association anti-gq antecedent sialic mfs patients guillain –barr syndrome miller campylobacter jejuni reactivity cohort mimicry symptom 6 months trial guillain-barr chapter serotype model antecedent infections factor disability figure antigen
10 Most Recent Publications
|
Siglec-7 specifically recognizes Campylobacter jejuni strains associated with oculomotor weakness in Guillain-Barré syndrome and Miller Fisher syndrome
(Article)
Heikema, A.P. Jacobs, B.C. Horst-Kreft, D. Huizinga, R. Kuijf, M.L. Endtz, H.P. Samsom, J.N. Wamel, W.J.B. van |
2012-11-27
|
|
Detection of antibodies in neuropathy patients by synthetic GM1 mimics
(Article)
Pukin, A.V. Jacobs, B.C. Tio-Gillen, A.P. Gilbert, M. Endtz, H.P. Belkum, A.F. van Visser, G.M. Zuilhof, H. |
2011-12-01
|
|
Neuropathophysiological potential of Guillain-Barré syndrome anti-ganglioside-complex antibodies at mouse motor nerve terminals
(Article)
Zitman, F.M.P. Greenshields, K. Plomp, J.J. Kuijf, M.L. Ueda, M. Kaida, K.I. Broos, L.A.M. Tio-Gillen, A.P. Jacobs, B.C. Kusunoki, S. Willison, H.J. |
2011-09-01
|
|
Guillain-Barré syndrome: Background incidence rates in the Netherlands
(Article)
Maas, N.A.T. van der Kramer, M.A. Jacobs, B.C. Soest, E.M. van Dieleman, J.P. Kemmeren, J.M. Melker, H.E. de Sturkenboom, M.C.J.M. |
2011-09-01
|
|
High incidence of guillain-barré syndrome in children, Bangladesh
(Article)
Islam, Z. Jacobs, B.C. Mohammad, Q.D. Diorditsa, S. Endtz, H.P. |
2011-07-01
|
|
Campylobacter jejuni lipooligosaccharides modulate dendritic cell-mediated T cell polarization in a sialic acid linkage-dependent manner
(Article)
Bax, M. Kuijf, M.L. Heikema, A.P. Rijs, W. van Bruijns, S.C.M. Garcia-Vallejo, J.J. Crocker, P.R. Jacobs, B.C. Vliet, S.J. van Kooyk, Y. van |
2011-07-01
|
|
Serum IgG levels as biomarkers for optimizing IVIg therapy in CIDP
(Article)
Doorn, P.A. van Kuitwaard, K. Jacobs, B.C. |
2011-06-01
|
|
Neuralgic amyotrophy associated with Bartonella henselae infection
(Article)
Stek, C.J. Eijk, J.J.J. van Jacobs, B.C. Enting, R. Sprenger, H.G. Alfen, N. van Assen, S. van |
2011-06-01
|
|
Screening for antecedent Campylobacter jejuni infections and anti-ganglioside antibodies in idiopathic neuralgic amyotrophy
(Article)
Eijk, J.J.J. van Alfen, N. van Tio-Gillen, A.P. Maas, M. Herbrink, P. Portier, R.P. Doorn, P.A. van Engelen, B.G.M. van Jacobs, B.C. |
2011-06-01
|
|
Selective depletion of neuropathy-related antibodies from human serum by monolithic affinity columns containing ganglioside mimics
(Article)
Tetala, K.K.R. Heikema, A.P. Jacobs, B.C. Beek, T.A. van Pukin, A.V. Weijers, C.A.G.M. Tio-Gillen, A.P. Gilbert, M. Endtz, H.P. Belkum, A.F. van Zuilhof, H. Visser, G.M. |
2011-05-26
|
